[HTML][HTML] Low molecular weight heparin in COVID-19: benefits and concerns

A Makarem, R Zareef, J Abourjeili, JE Nassar… - Frontiers in …, 2023 - frontiersin.org
Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health
worldwide and it scarred the medical, economical, and social determinants of health. Even …

[HTML][HTML] The potential role of heparin in patients with COVID-19: beyond the anticoagulant effect. A review

L Gozzo, P Viale, L Longo, DC Vitale… - Frontiers in …, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is responsible of
variable clinical manifestations, ranging from no symptoms to severe pneumonia with acute …

Heparin as a therapy for COVID-19: current evidence and future possibilities

JA Hippensteel, WB LaRiviere… - … of Physiology-Lung …, 2020 - journals.physiology.org
Coronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted nearly every …

Comprehensive landscape of heparin therapy for COVID-19

C Shi, W Tingting, JP Li, MA Sullivan, C Wang… - Carbohydrate …, 2021 - Elsevier
The pandemic coronavirus disease 2019 (COVID-19), caused by the infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading globally …

[HTML][HTML] Use of enoxaparin to counteract COVID-19 infection and reduce thromboembolic venous complications: a review of the current evidence

F Drago, L Gozzo, L Li, A Stella, B Cosmi - Frontiers in pharmacology, 2020 - frontiersin.org
The impact of the COVID-19 pandemic has been dramatic worldwide, with China, Italy, and
now US at its epicenter. Researchers and clinicians are studying and testing different …

[HTML][HTML] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

B Buijsers, C Yanginlar, ML Maciej-Hulme… - …, 2020 - thelancet.com
Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …

[HTML][HTML] The role of heparin in COVID-19: an update after two years of pandemics

M Mangiafico, A Caff, L Costanzo - Journal of Clinical Medicine, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous
thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial …

[HTML][HTML] The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients

E Reichman-Warmusz, O Warmusz, R Wojnicz - Open Medicine, 2022 - degruyter.com
Accumulated evidence suggest that the adverse outcome of severe coronavirus disease
2019 (COVID-19) is closely related to prothrombotic microvascular pathology with a high risk …

[HTML][HTML] The benefits of heparin use in COVID-19: pleiotropic antiviral activity beyond anticoagulant and anti-inflammatory properties

G Lippi, BM Henry, EJ Favaloro - Seminars in Thrombosis and …, 2023 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), a life-threatening infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing the worst …

[HTML][HTML] The use of the anticoagulant heparin and corticosteroid dexamethasone as prominent treatments for COVID-19

HA Braz-de-Melo, SS Faria… - Frontiers in …, 2021 - frontiersin.org
COVID-19 is spreading worldwide at disturbing rates, overwhelming global healthcare.
Mounting death cases due to disease complications highlight the necessity of describing …